Evolving Market Boundaries and Competition Policy Enforcement in the Pharmaceutical Industry
Micael Castanheira,
Georges Siotis and
Carmine Ornaghi
ULB Institutional Repository from ULB -- Universite Libre de Bruxelles
Abstract:
Competition investigations start with market definition, which establishes the perimeter of the competitive analysis. In this paper, we focus on the definition of economic markets in the pharmaceutical industry, where the entry of generics in different therapeutic areas provides a sequence of quasi-natural experiments involving a significant competitive shock for the originator producer. We show how generic entry modifies price and non-price competitive constraints over time, generating market-wide effects. Paradoxically, generic entry may soften the competitive pressure for brands other than the originator. We obtain these results by econometrically estimating time-varying price elasticities. We then apply the logic of the Hypothetical Monopolist Test to gauge the strength of competitive constraints under different market structures. Our results provide strong empirical support for an approach that defines relevant markets contingent on the theory of harm. We discuss the relevance of these findings in the context of ongoing cases.
Keywords: market definition; competition policy; antitrust; pharmaceutical industry (search for similar items in EconPapers)
JEL-codes: D22 I11 L13 (search for similar items in EconPapers)
Date: 2023-02-09
New Economics Papers: this item is included in nep-com, nep-ind and nep-reg
References: Add references at CitEc
Citations:
Published in: European journal of law and economics (2023) v.55,p.313–1348
Downloads: (external link)
https://dipot.ulb.ac.be/dspace/bitstream/2013/353440/4/s10657-022-09760-7 Full text for the whole work, or for a work part (application/octet-stream)
https://dipot.ulb.ac.be/dspace/bitstream/2013/3534 ... arket_definition.pdf Full text for the whole work, or for a work part (application/pdf)
Related works:
Journal Article: Evolving market boundaries and competition policy enforcement in the pharmaceutical industry (2023) 
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:ulb:ulbeco:2013/353440
Ordering information: This working paper can be ordered from
http://hdl.handle.ne ... lb.ac.be:2013/353440
Access Statistics for this paper
More papers in ULB Institutional Repository from ULB -- Universite Libre de Bruxelles Contact information at EDIRC.
Bibliographic data for series maintained by Benoit Pauwels ().